Press release
United States Next Generation Cancer Diagnostics Market: Size, Growth Factors and Industry Forecast 2022
A latest research report titled as ”United States Next Generation Cancer Diagnostics Market: Size, Growth Factors and Industry Forecast 2022” has been recently added to the vast portfolio of Market Research Hub (MRH) online research offerings. This report is a professional and in-depth analysis on the present state and future prospect for the global market. It provides valuable information to the industry insiders, potential entrants or investors. It includes an exhaustive enquiry with the reliability of logic and the comprehensiveness of contents.Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1003021
This report studies sales (consumption) of Next Generation Cancer Diagnostics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Next Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Protein Microarrays
DNA Microarrays
Split by applications, this report focuses on sales, market share and growth rate of Next Generation Cancer Diagnostics in each application, can be divided into
Lung Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Others
Table Of Content:
1 Next Generation Cancer Diagnostics Overview
1.1 Product Overview and Scope of Next Generation Cancer Diagnostics
1.2 Classification of Next Generation Cancer Diagnostics
1.2.1 Next Generation Sequencing
1.2.2 qPCR & Multiplexing
…………
2 United States Next Generation Cancer Diagnostics Competition by Manufacturers
2.1 United States Next Generation Cancer Diagnostics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Next Generation Cancer Diagnostics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Next Generation Cancer Diagnostics Average Price by Manufactures (2015 and 2016)
Continued…..
Bowse Full Report With TOC: http://www.marketresearchhub.com/report/united-states-next-generation-cancer-diagnostics-market-report-2017-report.html
In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Follow us on:
Twitter: twitter.com/MktResearchHub
LinkedIn: www.linkedin.com/company/market-research-hub
Facebook: www.facebook.com/MarketResearchHub/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Next Generation Cancer Diagnostics Market: Size, Growth Factors and Industry Forecast 2022 here
News-ID: 527385 • Views: …
More Releases from Medical Research Report

Genomic Health Inc (GHDX) - Product Pipeline Analysis: Size, Share, Growth, Tren …
“Genomic Health Inc Product Pipeline” is a provider of genomic-based clinical laboratory services for the treatment of cancer. The companys commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, and Onco type DX prostate cancer test. It perform extensive research and development activities to optimize the treatment of urologic cancers including prostate, bladder, and kidney cancers, and additional treatment decisions in breast and…

Foundation for Innovative New Diagnostics - Product Pipeline Analysis: Size, Sha …
Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured project management framework, product development services, buruli ulcer diagnosis, chagas disease diagnostic solutions, hat diagnostic solutions, and tuberclosis diagnostic solutions. FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV…

Exalenz Bioscience Ltd (EXEN) - Product Pipeline Analysis : Size, Share, Growth, …
Exalenz Bioscience Ltd (Exalenz) carries out the development and commercialization of advanced medical systems for a range of gastrointestinal (GI) tract and liver disorders. The company harnesses its BreathID technology platform for assessment and monitoring of functional diseases. Its flagship product, BreathID Hp is a urea breath test for diagnosing, monitoring and managing gastric Helicobacter pylori (H. pylori) infection in adults. The BreathID Hp is US Food and Drug Administration…

Latest Market Research In Hemorrhage Curing Industry Shows Constant Growth Until …
Albany, New York, March 20, 2017: Market Research Hub (MRH) has recently announced the addition of a new report to its expanding catalog of research reports, which it titled “Hemorrhage Pipeline Review, H1 2017“. The market research report examines executive’s opinion about the business environment. Additionally, the report provides comprehensive insight and analysis of the global market, the major players, the main trends, and consumer attitudes. The report delivers a…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…